Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-11

Clinical Trial Update: Effect of Beta-Glucan on Cholesterol Lowering [NA]

View source ↗

Summary

A completed clinical trial evaluated beta-glucan for cholesterol lowering in adults with hypercholesterolemia. Results were posted on 2014-03-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta Glucan (beta-glucan)

Snippet

Sponsor: University of Manitoba | Conditions: Hypercholesterolemia | NA | Status: COMPLETED | Results posted: 2014-03-11